First Bentley Systems Inc. (NASDAQ: BSY) sells software to the people that plan, design, and build infrastructure. These include engineers, architects, and construction firms. As money begins to flow into rebuilding infrastructure, there will be more demand for Bentley's software.
The Motley Fool recently released this piece identifying “3 Unstoppable Stocks That Can Crush Dogecoin”. The author argues that Dogecoin (CRYPTO:DOGE) is a bubble that’s going to burst, and that stocks are the better move right now.
iTeos Therapeutics debuts first data on TIGIT-targeting cancer immunotherapy, while Avalon Globocare shows 90...
iTeos presented the EOS-448 Phase 1 study results at the annual meeting of the American Association for Cancer Research on Saturday. The TIGIT class of immunotherapy drugs is drawing a lot of attention from academia, industry, and investors because of its potential to greatly expand the pool of patients who might benefit from so-called checkpoint inhibitors.
First Graphene Limited (ASX:FGR; “First Graphene” or “the Company”) is pleased to advise on positive progress regarding the Company’s collaborative project with world-leading researchers at the University of Warwick on the use of graphene in thermoplastic systems.
Sleep-Friendly Nutrition Emerging as a Global Wellness Focus, Nightfood CEO Featured Panelist at Healthspan
Miami, FL – May 5, 2021 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging...
With the rights to patented water systems technology after the acquisition of a 25-year-old company in Texas with a sterling reputation as a builder of custom industrial water treatment plants (and generating close to $4 million per year in sales while flying under Wall Street’s radar), OriginClear is leading the fast-growing business of helping industry cope with its own pollution.
U.S. government has invested $6 billion in Moderna’s Covid-19 vaccine while Avalon GloboCare works...
In 2016, Moderna received $8 million with the potential for up to $125 million from the Biomedical Advanced Research and Development Authority, a component of the U.S. Department of Health and Human Services, to accelerate development of an mRNA vaccine for Zika. (The company is still working on that project.)What makes the bankrolling of Moderna’s Covid-19 vaccine so extraordinary, Foroohar said, was the scale, which “reflects how unusual the pandemic is and the fact that this is very literally a once-in-a-lifetime event.”
From all over the country? Sounds like a plan. I mean, what could possibly go wrong? Now, don’t misunderstand me. I am as much for reopening as anyone; having both been infected by Covid-19 and vaccinated, I am a walking antibody—for certain strains, anyway. We should open here in New York and enjoy the summer; it will not be long before another strain starts to spread and brings all the fun, albeit temporarily, to a halt. Particularly if the unvaccinated continue to act moronically.
The following year, it was bought by Gilead NASDAQ: GILD and its immunotherapy subsidiary, Kite, for $567 million. Since then, Kite has begun recruiting for a clinical trial of its solid tumor CAR-T candidate, but it has not yet moved past Phase 1.
We’ve certainly all felt the recent volatility. In today's shifting economy, accredited investors—especially real estate investors—are looking for assets that can grow faster than inflation. They are learning that water is a stable and high-yield asset class that does especially well in hard times.
Global food & beverage giant Unilever (NYSE: UL), the world’s largest ice cream company, announced in March 2021 that they are launching a year-long study to identify how sleep can be improved through diet and nutrition. While Unilever and the other major food & beverage players are researching and exploring the concept of sleep-friendly nutrition, Nightfood is now establishing a national brand presence in leading supermarkets and hotels.
Specializing in research and development of graphene -- a wonder material known for its small size (consisting of a two-dimensional layer of atoms) and incredible strength -- First Graphene is also a force multiplier. This attribute was in full effect when the company announced a one-step process that converts petroleum feedstock (raw materials) to graphite and graphene materials.
Net shipments into China via the Shanghai Diamond Exchange (SDE) grew 393% year on year to $722 million during the three months ending March 31, the institution reported Tuesday. Import volume jumped 394% to 699,500 carats.
Category creators are often awarded a significant valuation premium in the consumer goods space, and the category Nightfood is pioneering shows major growth potential. As distribution and gross sales increase, Nightfood can benefit from the consumer quest for better sleep as projected by Pepsi and other global snack players
The three-year collaboration, announced Wednesday, has initial funding of $7.28 million.Current gene therapy approaches being developed for sickle cell disease are complex, enormously expensive, and bespoke, crafting treatments for individual patients one at a time. The collaboration aims to instead create an off-the-shelf treatment that bypasses many of the steps of current approaches, in which cells are removed and processed outside the body before being returned to patients.
In the article, the writer discusses the topic of dividends stocks, noting how they can provide “…an important source of investment income to a well-diversified portfolio.” Then going on to stress the importance of doing your due diligence when investing in a company—beyond simply flashy yields.
A Virtual Care Platform Covering Diagnosis to Treatment without leaving your Home The camera on your phone is more powerful than you know. The infrared aspect...
With revenues up more than 60% compared to last fiscal year-to-date, Nightfood has their sleep-friendly ice cream in over 800 stores including major divisions of the largest supermarket chains in the country such as Kroger (NYSE: KR), H-E-B, Albertsons (NYSE: ACI).
Why renewable energy? To quote the writer, “Renewable energy is making up an ever-larger proportion of energy production in the US, and there are publicly traded, dividend-paying stocks that allow investors to take advantage of this trend.”
Efficacy rates for China’s Covid vaccines have been found to be lower than those developed by Pfizer-BioNTech (NYSE PFE) (NASDAQ:BNTX) and Moderna. (NASDAQ MRNA) Earlier this month, the director of the Chinese Center for Disease Control publicly acknowledged that Chinese vaccines “don’t have very high protection rates” and that they were considering giving people different Covid shots to boost vaccine efficacy.
Take a look at ATWEC Technologies, Inc. (OTC Pink: ATWT). When it comes to child safety, there is no limit to what parents will spend for the benefit of their children, and they expect nothing less from their community.
Miami, FL–(April 29, 2021) – EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on NexTech AR Solutions (OTCQB: NEXCF).
Scientist who helped develop Pfizer-BioNTech Covid vaccine agrees third shot is needed as immunity...
The chief medical officer of BioNTech (NASDAQ BNTX) told CNBC on Wednesday that people will likely need a third shot of its two-dose Covid-19 vaccine as immunity against the virus wanes, agreeing with previous comments made by Pfizer CEO Albert Bourla. Dr. Ozlem Tureci, co-founder and CMO of BioNTech, which developed a Covid vaccine with Pfizer (NYSE: PFE), said she also expects people will need to get vaccinated against the coronavirus annually, like for the seasonal flu.
Amid all the interest in night snacking from global food and beverage giants, Nightfood remains the leader in this nascent category that many believe has billion-dollar potential. Dr. Oz stated in October, 2020, “The single most underappreciated problem in America, in fact, the world, is sleep.”
Companies that can most efficiently decarbonize the economy will likely see strong growth for decades to come, wrote Morgan Stanley analysts in a Friday note. The group identified five industries and representative stocks that could benefit from the development.
We are always on the lookout for excellent prospects, especially with promising dividends. After 2020, growth combined with stability is more enticing than ever. In fact, in today's shifting economy, accredited investors—especially real estate investors—are looking for assets that can grow faster than inflation. They are learning that water is a stable and high-yield asset class that does especially well in hard times.
EmergingGrowth.com on the ASX
This is one of several reasons why graphene has captured the imagination across the full spectrum of the applied sciences industry, from the experts running research and development to the individual investor seeking to capitalize and profit from the next technological innovation. A carbon allotrope consisting of a single atom layer arranged in a two-dimensional honeycomb lattice, graphene is simultaneously lightweight, resilient and incredibly strong.
Stocks In Play
Project Icewine is an onshore contiguous site that is about 200,000 acres, located in an area in Alaska’s that is known for being oil rich. The land was confirmed to have large oil and condensate repositories and is expected to be further appraised for more accurate findings.
Last week, Forbes explored the white-hot better-for-you food & beverage sector in light of Oatly’s plans to IPO with a valuation of an estimated $10B. That’s 25x top-line earnings. Here’s why that valuation might not be so crazy.
Barron’s screened for the companies whose expected earnings have risen the most since the start of the month, meaning analysts are getting more optimistic about them heading into earnings season. The four companies below saw increases of at least 15% between April 1 and April 26.